Tag:
Parkinsons Drug
Latest Headlines
Latest Headlines
Merck Serono returns rights to Parkinson's drug to Newron
Merck Serono has decided that the experimental Parkinson's disease drug safinamide won't be as strong a commercial drug as once thought. The company, a unit of Germany's Merck KGaA, has handed back
